The global luciferase assay market size was exhibited at USD 1,719 million in 2024 and is projected to hit around USD 3,413 million by 2034, growing at a CAGR of 7.1% during the forecast period 2024 to 2034.
The luciferase assay market is a prominent branch of the healthcare industry. This industry deals in the manufacturing and distribution of bioluminescent assays used for measuring biological activities in cells. There are several products manufactured in this industry consisting of beta-galactosidase assays, luciferase assays, fluorescent protein-related assays, chloramphenicol, and some others. The growing demand for drug delivery screening has driven the market growth. This market is expected to rise significantly with the growth of the biotechnology industry across the globe.
The increased popularity of these assays due to their compatibility with several products including kits, reagents, instruments, and some others has boosted the market growth. Also, the rise in the number of research institutes coupled with growing investment by the government of several countries for developing the biotechnology sector is playing a vital role in shaping the industry in a positive direction. Moreover, the rising application of these tools in gene expression, post-translational modification, protein-protein interaction, metabolic activity, and some others is projected to drive the growth of the luciferase assay market. The advancement in genetic engineering along with growing developments related to novel cytotoxicity assay is expected to create ample growth opportunities for the market players in the upcoming days.
Published by Ajit Bansod
